While an unfortunate diagnosis, as many patients with BRCA1/2 mutations are predisposed to develop multiple tumors, including breast cancer, its detection in ovarian cancer patients is paradoxically linked to a more favorable prognosis. This evidence concerns the gene BRCA1 and ovarian carcinoma.